Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-27

Clinical Trial Update: Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Detrol LA effects on overactive bladder symptoms, sexual quality of life, and sexual function in women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Detrol LA (tolterodine tartrate)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Urinary Incontinence | Phase 4 | Status: COMPLETED